DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Investigating the Effect of Micardis® on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

Information source: Boehringer Ingelheim Pharmaceuticals
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hypertension

Intervention: telmisartan (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Boehringer Ingelheim Pharmaceuticals

Official(s) and/or principal investigator(s):
Boehringer Ingelheim, Study Chair, Affiliation: Boehringer Ingelheim Pharmaceuticals

Overall contact:
Boehringer Ingelheim Study Coordinator, Phone: 1-800-243-0127, Email: clintriage.rdg@boehringer-ingelheim.com

Summary

Practical experience report (PER) investigating the effect of Micardis® on the average 24h blood pressure of therapy-naive and therapy-experienced patients

Clinical Details

Official title: 24h BP Under Micardis in Daily Practice

Study design: Case-Only, Prospective

Primary outcome: collect significant data on powerful BP reduction of Telmisartan in the context of 24h BP reduction after a 6 to 8 week treatment period

Secondary outcome: drug safety, efficacy and tolerability of Telmisartan

Eligibility

Minimum age: 18 Years. Maximum age: 95 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

1. Patients who have recently been diagnosed with hypertension

2. Patients whose current blood pressure treatment are inadequate and needs to be revised are suitable for inclusion.

Exclusion Criteria:

None (according to investigator)

Locations and Contacts

Boehringer Ingelheim Study Coordinator, Phone: 1-800-243-0127, Email: clintriage.rdg@boehringer-ingelheim.com

Boehringer Ingelheim Investigational Site, Adligenswil, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Aesch BL, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Baar, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Bad Ragaz, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Balgach, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Balsthal, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Basel, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Bassersdorf, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Belfaux, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Bern, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Bex, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Biberist, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Biel/Bienne, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Biglen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Bonaduz, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Bonstetten, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Bronschhofen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Bülach, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Bürglen UR, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Cernier, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Cham, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Chur, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Conthey, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Cornaux NE, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Cortaillod, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Davos Platz, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Domat/Ems, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Dornach, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Ebikon, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Embrach, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Emmetten, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Ennetbürgen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Eschen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Fehraltorf, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Flawil, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Fleurier, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Fribourg, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Glattfelden, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Hausen am Albis, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Heerbrugg, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Herrliberg, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Ittigen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Jenaz, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Kilchberg ZH, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Koblenz, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Kreuzlingen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Kriens, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, La Tour-de-Peilz, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Laupen ZH, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Lausanne, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Le Locle, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Liebefeld, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Näfels, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Neuheim, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Neyruz FR, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Nidau, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Niederdorf, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Oetwil am See, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Orbe, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Rapperswil SG, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Reinach BL, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Riehen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Rothenburg, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Sarnen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Savièse, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Saxon, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Schaffhausen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Schänis, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Schiers, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Sierre, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Sion, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, St. Gallen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Staad SG, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, St-Blaise, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, St-Maurice, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Sursee, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Teufenthal AG, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Thalwil, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Thierrens, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Thun, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Uznach, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Val-d'Illiez, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Vionnaz, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Wallisellen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Walzenhausen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Wettingen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Wetzikon ZH, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Wilen b. Wil, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Wohlen AG, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Wolhusen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Würenlos, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Yverdon-les-Bains, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Zollikofen, Switzerland; Recruiting

Boehringer Ingelheim Investigational Site, Zürich, Switzerland; Recruiting

Additional Information

Starting date: April 2009
Last updated: September 24, 2009

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009